MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma (Q48656685)

14 February 2018

title

MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma (English)

1 reference

14 February 2018

author

Marco Scarpa

5

1 reference

14 February 2018

Angelo Paolo Dei Tos

8

1 reference

14 February 2018

author name string

L Toffolatti

1

1 reference

14 February 2018

E Scquizzato

2

1 reference

14 February 2018

S Cavallin

3

1 reference

14 February 2018

F Canal

4

1 reference

14 February 2018

P M Stefani

6

1 reference

14 February 2018

F Gherlinzoni

7

1 reference

14 February 2018

publication date

17 July 2014

1 reference

14 February 2018

published in

Virchows Archiv

1 reference

14 February 2018

volume

465

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

579-586

1 reference

14 February 2018

Variability and regulation of O6-alkylguanine-DNA alkyltransferase

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

MGMT methylation: a marker of response to temozolomide in low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

The role of MGMT testing in clinical practice: a report of the association for molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

RNA-mediated neurodegeneration in repeat expansion disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

MethyLight: a high-throughput assay to measure DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Molecular diagnostics of gliomas: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Complex disease, gender and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Aging and epigenetics: longitudinal changes in gene-specific DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Epigenetic-aging-signature to determine age in different tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1622-6

Primary central nervous system lymphoma

21 January 2018

1 reference

12 December 2020

Hierarchical clustering of lung cancer cell lines using DNA methylation markers

1 reference

12 December 2020

Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma

1 reference

12 December 2020

Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma

1 reference

12 December 2020

Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma

1 reference

12 December 2020

Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.

1 reference

12 December 2020

Concepts in use of high-dose methotrexate therapy.

1 reference

12 December 2020

The DNA repair protein O6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea

1 reference

12 December 2020

MGMT analysis at DNA, RNA and protein levels in glioblastoma tissue

1 reference

12 December 2020

Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma

1 reference

12 December 2020

Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.

1 reference

12 December 2020

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years

1 reference

12 December 2020

MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression

1 reference

12 December 2020

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

12 December 2020

10.1007/S00428-014-1622-6

Identifiers

DOI

1 reference

14 February 2018

release_mdlaykep7rfn5fj5qt4as5l6wa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mdlaykep7rfn5fj5qt4as5l6wa

24 November 2022

mapped directly with Wikidata item

1 reference

14 February 2018